The senior vice president and head of medical affairs at Orca Bio discussed how Orca-T has been developed to lower the risk of graft-versus-host disease.
Irene Agodoa, MD
Advertisement
Articles by Irene Agodoa, MD
The senior vice president and head of medical affairs at Orca Bio discussed the initiation of the Precision-T phase 3 trial.
Advertisement
Latest Updated Articles
Irene Agodoa, MD, on Addressing GVHD Risks in Treating Hematologic MalignanciesPublished: August 26th 2022 | Updated:
